First medication in new class of ARTs poised to be available for salvage therapy. Tropism testing helps determine best patients for drug.
D019380:Anti-HIV Agents / Q000494:pharmacology / Q000627:therapeutic use*; D065100:CCR5 Receptor Antagonists; D018791:CD4 Lymphocyte Count; D003510:Cyclohexanes / Q000494:pharmacology / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D000077592:Maraviroc; D016879:Salvage Therapy; D014230:Triazoles / Q000494:pharmacology / Q000627:therapeutic use*; D018523:Tropism / Q000187:drug effects*; D019562:Viral Load
D019380:Anti-HIV Agents; D065100:CCR5 Receptor Antagonists; D003510:Cyclohexanes; D014230:Triazoles; D000077592:Maraviroc